Launch week offerEnds in00h00m00s

annual Promonthly Pro

Christophe LE TERRIER

University of Fribourg

Switzerland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Switzerland Professors in Microbiology Microbiology professors in Switzerland

Articles (26)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (13)

Sabrina Pagano

Geneva University Hospitals (HUG)

SWITZERLAND

View details

Silvia Stringhini

Associate Professor

The University of British Columbia

CANADA

View details

Patrice Nordmann

Head

University of Fribourg

SWITZERLAND

View details

Tinh‐Hai Collet

SWITZERLAND

View details

Mustafa Sadek

Lecturer

University of Fribourg

SWITZERLAND

View details

Aurelien Thomas

Professor-Head of Unit

University of Lausanne

SWITZERLAND

View details

Frank Chemouni

Head of the Cardiac Intensive Care Unit

Institute Mutualiste Montsouris

FRANCE

View details

Nicolas Mongardon

Assistance Publique - Hôpitaux de Paris

FRANCE

View details

Jacqueline Findlay

Senior Researcher

University of Fribourg

SWITZERLAND

View details

Katia Iglesias

Professor associated UAS

University of Applied Sciences and Arts Northwestern Switzerland

SWITZERLAND

View details

Hannah Wozniak

University Hospital of Geneva

SWITZERLAND

View details

Otávio Hallal Ferreira Raro

University of Fribourg

SWITZERLAND

View details

Laurent Poirel

Assistant Professor

University of Fribourg

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christophe LE TERRIER

Research Interests

Make your next move.

Explore related searches

Articles (26)

Relative inhibitory activities of taniborbactam and xeruborbactam against KPC variants conferring reduced susceptibility or resistance to ceftazidime/avibactam, cefiderocol, and cefepime/taniborbactam

In vitro activity of β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with aztreonam against metallo-β-lactamase producing Escherichia coli clinical isolates

Rapid detection of cefepime-taniborbactam susceptibility/resistance in Enterobacterales

The emerging concern of IMP variants being resistant to the only IMP-type metallo-β-lactamase inhibitor, xeruborbactam

In-vitro activity of newly-developed β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with anti-pseudomonal β-lactam antibiotics against AmpC-overproducing clinical Pseudomonas aeruginosa isolates

Inhibitory activity of meso-dimercaptosuccinic acid against IMP metallo-β-lactamase variants in Pseudomonas aeruginosa

Broad spectrum of β-lactamase coverage and potent antimicrobial activity of xeruborbactam in combination with meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new β-lactam/β-lactamase inhibitor combinations

In-vitro activity of the novel β-lactam/β-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 2022

Impact of extended-spectrum chromosomal AmpC (ESAC) of Escherichia coli on susceptibility to cefiderocol

Impact of intensive prone position therapy on outcomes in intubated patients with ARDS related to COVID-19

Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor xeruborbactam in comparison with taniborbactam against metallo-β-lactamases produced in Escherichia coli and Pseudomonas aeruginosa

Effect of modification of penicillin-binding protein 3 on susceptibility to ceftazidime-avibactam, imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam, cefepime-taniborbactam, and cefiderocol of Escherichia coli strains producing broad-spectrum β-lactamases

Pulmonary embolism impacts clinical outcomes of intubated patients with acute respiratory distress syndrome related to COVID-19

Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamases

Structural basis of metallo-β-lactamase resistance to taniborbactam

Multidrug-resistant Gram-negative clinical isolates with reduced susceptibility/resistance to cefiderocol: which are the best present and future therapeutic alternatives?

Association of Trace Element Levels with Outcomes in Critically Ill COVID-19 Patients

Anaesthetic and peri-operative management for thrombectomy procedures in stroke patients

Impact of acquired broad-spectrum β-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam β-lactamase inhibitors in Escherichia coli

Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern

No waiting lying in a corridor: a quality improvement initiative in an emergency department

Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa

In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates

In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR Enterobacterales and Pseudomonas aeruginosa producing metallo-β-lactamases

Protocol Title: Effect of POsitive therapeutic communication on PAIN and anxiety during arterial blood gas standardized procedures in the emergency department compared with traditional communication: a monocentric randomized controlled trial (Preprint)

Impact of nutritional therapy during the first wave of the COVID-19 pandemic in intensive care patients: A retrospective observational study

Collaborators (13)

Sabrina Pagano

Silvia Stringhini

Patrice Nordmann

Tinh‐Hai Collet

Mustafa Sadek

Aurelien Thomas

Frank Chemouni

Nicolas Mongardon

Jacqueline Findlay

Katia Iglesias

Hannah Wozniak

Otávio Hallal Ferreira Raro

Laurent Poirel

Make your next move.